Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Cereb Cortex ; 33(4): 1263-1276, 2023 02 07.
Article in English | MEDLINE | ID: mdl-35368053

ABSTRACT

Alzheimer's disease is linked to increased levels of amyloid beta (Aß) in the brain, but the mechanisms underlying neuronal dysfunction and neurodegeneration remain enigmatic. Here, we investigate whether organizational characteristics of functional presynaptic vesicle pools, key determinants of information transmission in the central nervous system, are targets for elevated Aß. Using an optical readout method in cultured hippocampal neurons, we show that acute Aß42 treatment significantly enlarges the fraction of functional vesicles at individual terminals. We observe the same effect in a chronically elevated Aß transgenic model (APPSw,Ind) using an ultrastructure-function approach that provides detailed information on nanoscale vesicle pool positioning. Strikingly, elevated Aß is correlated with excessive accumulation of recycled vesicles near putative endocytic sites, which is consistent with deficits in vesicle retrieval pathways. Using the glutamate reporter, iGluSnFR, we show that there are parallel functional consequences, where ongoing information signaling capacity is constrained. Treatment with levetiracetam, an antiepileptic that dampens synaptic hyperactivity, partially rescues these transmission defects. Our findings implicate organizational and dynamic features of functional vesicle pools as targets in Aß-driven synaptic impairment, suggesting that interventions to relieve the overloading of vesicle retrieval pathways might have promising therapeutic value.


Subject(s)
Amyloid beta-Peptides , Synaptic Vesicles , Synaptic Vesicles/physiology , Amyloid beta-Peptides/metabolism , Presynaptic Terminals/physiology , Neurons/metabolism , Hippocampus/physiology , Synaptic Transmission/physiology
2.
J Physiol ; 590(7): 1585-97, 2012 Apr 01.
Article in English | MEDLINE | ID: mdl-22271866

ABSTRACT

Most presynaptic terminals in the central nervous system are characterized by two functionally distinct vesicle populations: a recycling pool, which supports action potential-driven neurotransmitter release via vesicle exocytosis, and a resting pool. The relative proportions of these two pools are highly variable between individual synapses, prompting speculation on their specific relationship, and on the possible functions of the resting pool.Using fluorescence imaging of FM-styryl dyes and synaptophysinI-pHluorin(sypHy) as well as correlative electronmicroscopy approaches, we show here that Hebbian plasticity-dependent changes in synaptic strength in rat hippocampal neurons can increase the recycling pool fraction at the expense of the resting pool in individual synaptic terminals. This recruitment process depends on NMDA-receptor activation, nitric oxide signalling and calcineurin and is accompanied by an increase in the probability of neurotransmitter release at individual terminals. Blockade of actin-mediated intersynaptic vesicle exchange does not prevent recycling pool expansion demonstrating that vesicle recruitment is intrasynaptic.We propose that the conversion of resting pool vesicles to the functionally recycling pool provides a rapid mechanism to implement long-lasting changes in presynaptic efficacy.


Subject(s)
Hippocampus/physiology , Neurons/physiology , Presynaptic Terminals/physiology , Receptors, N-Methyl-D-Aspartate/physiology , Synaptic Vesicles/physiology , Animals , Calcineurin/physiology , Calcineurin Inhibitors , Enzyme Inhibitors/pharmacology , Hippocampus/cytology , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/physiology , Nitroarginine/pharmacology , Rats , Synaptic Transmission/physiology , Tacrolimus/pharmacology
3.
Biochem J ; 441(2): 579-90, 2012 Jan 15.
Article in English | MEDLINE | ID: mdl-21955321

ABSTRACT

Aß42 [amyloid-ß peptide-(1-42)] plays a central role in Alzheimer's disease and is known to have a detrimental effect on neuronal cell function and survival when assembled into an oligomeric form. In the present study we show that administration of freshly prepared Aß42 oligomers to a neuroblastoma (SH-SY5Y) cell line results in a reduction in survival, and that Aß42 enters the cells prior to cell death. Immunoconfocal and immunogold electron microscopy reveal the path of the Aß42 with time through the endosomal system and shows that it accumulates in lysosomes. A 24 h incubation with Aß results in cells that have damaged lysosomes showing signs of enzyme leakage, accumulate autophagic vacuoles and exhibit severely disrupted nuclei. Endogenous Aß is evident in the cells and the results of the present study suggest that the addition of Aß oligomers disrupts a crucial balance in Aß conformation and concentration inside neuronal cells, resulting in catastrophic effects on cellular function and, ultimately, in cell death.


Subject(s)
Amyloid beta-Peptides/pharmacology , Autophagy/physiology , Neuroblastoma/pathology , Peptide Fragments/pharmacology , Alzheimer Disease/physiopathology , Amyloid beta-Peptides/metabolism , Cathepsin D/metabolism , Cell Line, Tumor , Clathrin/metabolism , Hippocampus/metabolism , Humans , Lysosomes/pathology , Microscopy, Confocal , Microscopy, Electron, Transmission , Neuroblastoma/metabolism , Peptide Fragments/metabolism
4.
Nat Commun ; 2: 531, 2011 Nov 08.
Article in English | MEDLINE | ID: mdl-22068598

ABSTRACT

Fast neuronal signalling relies on highly regulated vesicle fusion and recycling at specialized presynaptic terminals. Recently, examples of non-classical neurotransmission have also been reported, where fusion of vesicles can occur at sites remote from conventional synapses. This has potentially broad biological implications, but the underlying mechanisms are not well established. Here we show that a complete vesicle recycling pathway can occur at discrete axonal sites in mature hippocampal neurons and that extrasynaptic fusion is a robust feature of native tissue. We demonstrate that laterally mobile vesicle clusters trafficking between synaptic terminals become transiently stabilized by evoked action potentials and undergo complete but delayed Ca(2+)-dependent fusion along axons. This fusion is associated with dynamic actin accumulation and, subsequently, vesicles can be locally recycled, re-acidified and re-used. Immunofluorescence and ultrastructural work demonstrates that extrasynaptic fusion sites can have apposed postsynaptic specializations, suggesting that mobile vesicle recycling may underlie highly dynamic neuron-neuron communication.


Subject(s)
Hippocampus/cytology , Neurons/metabolism , Action Potentials/physiology , Animals , Cells, Cultured , Electrophysiology , Fluorescent Antibody Technique , Hippocampus/ultrastructure , In Vitro Techniques , Microscopy, Electron, Transmission , Neurons/ultrastructure , Presynaptic Terminals/metabolism , Presynaptic Terminals/ultrastructure , Rats , Synaptic Transmission/physiology , Synaptic Vesicles/metabolism , Synaptic Vesicles/ultrastructure
5.
Neuron ; 66(1): 37-44, 2010 Apr 15.
Article in English | MEDLINE | ID: mdl-20399727

ABSTRACT

Synapse-specific vesicle pools have been widely characterized at central terminals. Here, we demonstrate a vesicle pool that is not confined to a synapse but spans multiple terminals. Using fluorescence imaging, correlative electron microscopy, and modeling of vesicle dynamics, we show that some recycling pool vesicles at synapses form part of a larger vesicle "superpool." The vesicles within this superpool are highly mobile and are rapidly exchanged between terminals (turnover: approximately 4% of total pool/min), significantly changing vesicular composition at synapses over time. In acute hippocampal slices we show that the mobile vesicle pool is also a feature of native brain tissue. We also demonstrate that superpool vesicles are available to synapses during stimulation, providing an extension of the classical recycling pool. Experiments using focal BDNF application suggest the involvement of a local TrkB-receptor-dependent mechanism for synapse-specific regulation of presynaptic vesicle pools through control of vesicle release and capture to or from the extrasynaptic pool.


Subject(s)
Hippocampus/metabolism , Neurons/metabolism , Presynaptic Terminals/metabolism , Synaptic Vesicles/metabolism , Animals , Cells, Cultured , Hippocampus/ultrastructure , In Vitro Techniques , Models, Biological , Neurons/ultrastructure , Presynaptic Terminals/ultrastructure , Rats , Rats, Sprague-Dawley , Synaptic Vesicles/ultrastructure
6.
Exp Eye Res ; 84(6): 1135-9, 2007 Jun.
Article in English | MEDLINE | ID: mdl-16635487

ABSTRACT

An artificial mutant Ala25Ser precursor cystatin C was created to help elucidate the cause of intracellular mis-localisation of the biochemically related variant B (Ala25Thr) precursor cystatin C to the mitochondria. Homozygotes of variant B precursor cystatin C were reported to carry an increased susceptibility to developing the exudative form of AMD. Ala25Ser precursor cystatin C shows a dual distribution to the Golgi apparatus and to the mitochondria. This localisation is thus intermediary between that of wild-type cystatin C (targeted to ER/Golgi compartment) and that of variant B precursor cystatin C. Furthermore, the level of secretion of Ala25Ser cystatin C by RPE cells is intermediary between wild type and variant B cystatin C. Ala25Ser precursor cystatin C thus represents a biochemical intermediate between the wild type and the AMD-associated cystatin C and as such, is a novel tool for the investigation of the mechanism of intracellular mis-localisation of variant B cystatin C. Our findings further support the hypothesis that substitution of the alanine residue in the penultimate position of precursor cystatin C signal sequence with a less hydrophobic amino acid residue, such as threonine (as in variant B cystatin C) or serine is sufficient to impair the intracellular trafficking and processing of the protein.


Subject(s)
Cystatins/genetics , Macular Degeneration/genetics , Cystatin C , Genetic Predisposition to Disease , Golgi Apparatus/metabolism , Humans , Mitochondria/metabolism
7.
Int J Biochem Cell Biol ; 39(1): 85-92, 2007.
Article in English | MEDLINE | ID: mdl-17035068

ABSTRACT

Osteonectin is a glycoprotein that modulates several aspects of cellular behaviour including proliferation and adhesion. The retinal pigment epithelium forms a continuous monolayer of polarised cells immediately bellow the neuroretina, and is integral to the homeostasis of photoreceptor cells. While osteonectin is expressed by normal retinal pigment epithelium in situ, its expression is significantly increased in retinal pigment epithelial cells associated with several common retinal diseases. This pattern of expression implies an important role for osteonectin in the biology of retinal pigment epithelial cells. However, the trafficking, processing, and eventual fate of osteonectin in these cells is not clear at present. Although the theoretical report of a leader sequence within the osteonectin open reading frame and its extracellular presence in some tissues indirectly support secretion of the protein, there is no direct experimental demonstration of the secretion route to date. As a first step towards understanding the role of osteonectin in retinal pigment epithelium, we studied the intracellular distribution and trafficking of the protein in living cells. Here, we present experimental evidence that a precursor osteonectin fusion protein is targeted to the endoplasmic reticulum/Golgi pathway, with a likely basal secretion in retinal pigment epithelial cells. In addition, we show that the precursor osteonectin protein having the leader sequence masked fails to undergo secretion leading to cell death, a phenotype which may be of relevance not only for retinal pathology, but also for other diseases such as the bone disorder known as pseudoachondroplasia that is associated with a lack of osteonectin secretion.


Subject(s)
Golgi Apparatus/metabolism , Osteonectin/metabolism , Pigment Epithelium of Eye/metabolism , Achondroplasia/metabolism , Cell Adhesion/physiology , Cell Death , Cell Line , Cell Polarity/physiology , Cell Proliferation , Humans , Photoreceptor Cells/cytology , Photoreceptor Cells/metabolism , Pigment Epithelium of Eye/cytology , Protein Sorting Signals/genetics , Protein Transport/genetics , Protein Transport/physiology , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism
8.
Traffic ; 5(11): 884-95, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15479453

ABSTRACT

Cystatin C is abundantly expressed by the retinal pigment epithelium (RPE) of the eye. Targeting of cystatin C to the Golgi apparatus and processing through the secretory pathway of RPE cells are dependent upon a 26-amino acid signal sequence of precursor cystatin C. A variant with an alanine (A) to threonine (T) mutation in the penultimate amino acid of the signal sequence (A25T) was recently correlated with increased risk of developing exudative age-related macular degeneration. The biochemical consequence of the A25T mutation upon targeting of the protein is reported here. Targeting and trafficking of full-length mutant (A25T) precursor cystatin C-enhanced green fluorescent protein fusion protein were studied in living, cultured retinal pigment epithelial and HeLa cells. Confocal microscopy studies were substantiated by immunodetection. In striking contrast to wild-type precursor cystatin C fusion protein conspicuously targeted to the Golgi apparatus, the threonine variant was associated principally with mitochondria. Some diffuse fluorescence was also observed throughout the cytoplasm and nucleus (but not nucleoli). Secretion of fusion protein derived from the threonine variant was reduced by approximately 50% compared with that of the wild-type cystatin C fusion protein. Expression of the variant fusion protein did not appear to impair expression or secretion of endogenous cystatin C.


Subject(s)
Cystatins/biosynthesis , Macular Degeneration/genetics , Aging , Alanine/chemistry , Blotting, Western , Cell Nucleus/metabolism , Cells, Cultured , Cystatins/genetics , Cystatins/metabolism , Cytoplasm/metabolism , DNA Primers/chemistry , Electrophoresis, Polyacrylamide Gel , Golgi Apparatus/metabolism , Green Fluorescent Proteins/metabolism , HeLa Cells , Humans , Microscopy, Confocal , Microscopy, Fluorescence , Mitochondria/metabolism , Mitochondria/pathology , Mutagenesis, Site-Directed , Mutation , Pigment Epithelium of Eye/cytology , Plant Proteins , Plasmids/metabolism , Protein Structure, Tertiary , Threonine/chemistry , Time Factors , Transfection , Trypsin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...